Skip to main content

and
  1. Article

    Open Access

    Author Correction: Liquid biopsy epigenomic profiling for cancer subty**

    Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato in Nature Medicine (2024)

  2. Article

    Open Access

    Author Correction: Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

    Paolo Tarantino, Hersh Gupta, Melissa E. Hughes, Janet Files in Nature Communications (2023)

  3. Article

    Open Access

    Comprehensive genomic characterization of HER2-low and HER2-0 breast cancer

    The molecular underpinnings of HER2-low and HER2-0 (IHC 0) breast tumors remain poorly defined. Using genomic findings from 1039 patients with HER2-negative metastatic breast cancer undergoing next-generation ...

    Paolo Tarantino, Hersh Gupta, Melissa E. Hughes, Janet Files in Nature Communications (2023)

  4. Article

    Open Access

    Liquid biopsy epigenomic profiling for cancer subty**

    Although circulating tumor DNA (ctDNA) assays are increasingly used to inform clinical decisions in cancer care, they have limited ability to identify the transcriptional programs that govern cancer phenotypes...

    Sylvan C. Baca, Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato in Nature Medicine (2023)

  5. No Access

    Article

    Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis

    Molecular subty** of bladder cancer has revealed luminal tumors generally have a more favourable prognosis. However, some aggressive forms of variant histology, including micropapillary, are often classified...

    Joep J. de Jong, Begoña P. Valderrama, Julia Perera in British Journal of Cancer (2022)

  6. Article

    Open Access

    Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer

    The androgen receptor (AR) is a prostate master transcription factor. It binds to genetic enhancers, where it regulates gene activity and plays a fundamental role in prostate pathophysiology. Previous work has...

    Tesa Severson, **ntao Qiu, Mohammed Alshalalfa, Martin Sjöström in Clinical Epigenetics (2022)

  7. No Access

    Article

    Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence

    Esophageal squamous cell carcinomas (ESCCs) harbor recurrent chromosome 3q amplifications that target the transcription factor SOX2. Beyond its role as an oncogene in ESCC, SOX2 acts in development of the squa...

    Zhong Wu, ** Zhou, **aoyang Zhang, Zhouwei Zhang, Yingtian **e in Nature Genetics (2021)

  8. Article

    Open Access

    Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer

    No consensus currently exist on the optimal treatment of patients with high-risk nonmuscle invasive (HGT1) micropapillary variant of bladder cancer (MPBC). Transcripsome analysis may allow stratification of MP...

    Michaela Bowden, Rosa Nadal, Chensheng W. Zhou, Lillian Werner in Scientific Reports (2020)

  9. Article

    Open Access

    Clonal tracing reveals diverse patterns of response to immune checkpoint blockade

    Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of IC...

    Shengqing Stan Gu, **aoqing Wang, **hao Hu, Peng Jiang, Ziyi Li in Genome Biology (2020)

  10. Article

    Open Access

    Integrative analyses of single-cell transcriptome and regulome using MAESTRO

    We present Model-based AnalysEs of Transcriptome and RegulOme (MAESTRO), a comprehensive open-source computational workflow (http://github.com/liulab-dfci/MAESTRO)...

    Chenfei Wang, Dongqing Sun, **n Huang, Changxin Wan, Ziyi Li, Ya Han in Genome Biology (2020)

  11. Article

    Open Access

    Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models

    T- and NK-cell lymphomas (TCL) are a heterogenous group of lymphoid malignancies with poor prognosis. In contrast to B-cell and myeloid malignancies, there are few preclinical models of TCLs, which has hampere...

    Samuel Y. Ng, Noriaki Yoshida, Amanda L. Christie, Mahmoud Ghandi in Nature Communications (2018)

  12. No Access

    Article

    Broadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity

    A study investigating the mechanisms underlying lateral inhibition and lineage plasticity in the mouse small intestine crypts in vivo finds that crypt cells maintain a permissive chromatin state upon which a tran...

    Tae-Hee Kim, Fugen Li, Isabel Ferreiro-Neira, Li-Lun Ho, Annouck Luyten in Nature (2014)

  13. No Access

    Article

    Refined DNase-seq protocol and data analysis reveals intrinsic bias in transcription factor footprint identification

    Detailed analysis of DNase-seq protocols reveals the importance of choosing the right enzyme concentration and fragment length and cautions that many transcription factor footprints may represent cutting bias.

    Housheng Hansen He, Clifford A Meyer, Sheng'en Shawn Hu, Mei-Wei Chen in Nature Methods (2014)

  14. Article

    Open Access

    A closer look into DNase I hypersensitivity

    Housheng Hansen He, Clifford A Meyer, Henry Long, X Shirley Liu in Epigenetics & Chromatin (2013)